Inhibitors of protease-activated receptor 4 (PAR4): a review of recent patents (2013 –2021)

.

Source: Expert Opinion on Therapeutic Patents - February 17, 2022 Category: Drugs & Pharmacology Authors: Xiangying Yu Shanshan Li Xiong Zhu Yi Kong Source Type: research